Search

Your search keyword '"Bruni, Alessio"' showing total 272 results
Start Over Author "Bruni, Alessio" Search Limiters Academic (Peer-Reviewed) Journals
272 results on '"Bruni, Alessio"'

1. Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC study

Author

Nardone, Valerio, Bruni, Alessio, Franceschini, Davide, Marini, Beatrice, Vagge, Stefano, Ciammella, Patrizia, Sepulcri, Matteo, Cappelli, Anna, D’Angelo, Elisa, De Marco, Giuseppina, Angrisani, Antonio, Manetta, Mattia, Scricciolo, Melissa, Guida, Cesare, Aiello, Dario, Borghetti, Paolo, and Cappabianca, Salvatore

Published
2024
Full Text
View/download PDF

2. Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)

Author

Ingrosso, Gianluca, Ponti, Elisabetta, Francolini, Giulio, Caini, Saverio, Fondelli, Simona, Santini, Roberto, Valeriani, Maurizio, Rago, Luciana, Duroni, Giacomo, Bruni, Alessio, Augurio, Antonietta, Tramacere, Francesco, Trippa, Fabio, Russo, Donatella, Bottero, Marta, Tamburo, Maria, Parisi, Silvana, Borghesi, Simona, Lancia, Andrea, Gomellini, Sara, Scoccianti, Silvia, Stefanacci, Marco, Vullo, Gianluca, Statuto, Teodora, Miranda, Giulia, Santo, Bianca, Di Marzo, Alessandro, Bellavita, Rita, Vinciguerra, Annamaria, Livi, Lorenzo, Aristei, Cynthia, Bertini, Niccolò, Orsatti, Carolina, and Detti, Beatrice

Published
2024
Full Text
View/download PDF

3. PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative “triplet” for oligometastatic hormone sensitive prostate cancer patients

Author

Francolini, Giulio, Porreca, Angelo, Facchini, Gaetano, Santini, Daniele, Bruni, Alessio, Simoni, Nicola, Trovò, Marco, Osti, Mattia Falchetto, Fornarini, Giuseppe, Sisani, Michele, Di Cataldo, Vanessa, Detti, Beatrice, Garlatti, Pietro, Bertini, Niccolò, Serni, Sergio, Minervini, Andrea, and Livi, Lorenzo

Published
2024
Full Text
View/download PDF

4. Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort

Author

Borghetti, Paolo, Facheris, Giorgio, Ciammella, Patrizia, Galaverni, Marco, Granello, Lorenzo, Scotti, Vieri, Franceschini, Davide, Romei, Andrea, Giaj Levra, Niccolò, Federico, Manuela, La Vecchia, Maria, Merlotti, Anna, Sepulcri, Matteo, Piperno, Gaia, Marvaso, Giulia, Simoni, Nicola, Alì, Emanuele, Pontoriero, Antonio, Cappelli, Anna, Dionisi, Valeria, Menis, Jessica, Martino, Antonella, Vagge, Stefano, Canova, Stefania, Montesi, Giampaolo, Cuccia, Francesco, Boldrini, Luca, Franzese, Ciro, Grisanti, Salvatore, Bruni, Alessio, and Scorsetti, Marta

Published
2024
Full Text
View/download PDF

6. A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study

Author

Nicosia, Luca, Franceschini, Davide, Perrone-Congedi, Francesca, Molinari, Alessandro, Gerardi, Marianna Alessandra, Rigo, Michele, Mazzola, Rosario, Perna, Marco, Scotti, Vieri, Fodor, Andrei, Iurato, Aurelia, Pasqualetti, Francesco, Gadducci, Giovanni, Chiesa, Silvia, Niespolo, Rita Marina, Bruni, Alessio, Cappelli, Anna, D'Angelo, Elisa, Borghetti, Paolo, Di Marzo, Alessandro, Ravasio, Andrea, De Bari, Berardino, Sepulcri, Matteo, Aiello, Dario, Mortellaro, Gianluca, Sangalli, Claudia, Franceschini, Marzia, Montesi, Giampaolo, Aquilanti, Francesco Maria, Lunardi, Gianluigi, Valdagni, Riccardo, Fazio, Ivan, Scarzello, Giovanni, Vavassori, Vittorio, Maranzano, Ernesto, Maria Magrini, Stefano, Arcangeli, Stefano, Gambacorta, Maria Antonietta, Valentini, Vincenzo, Paiar, Fabiola, Ramella, Sara, Di Muzio, Nadia Gisella, Loi, Mauro, Jereczek-Fossa, Barbara Alicja, Casamassima, Franco, Osti, Mattia Falchetto, Scorsetti, Marta, and Alongi, Filippo

Published
2023
Full Text
View/download PDF

8. Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis

Author

Francolini, Giulio, Jereczek-Fossa, Barbara Alicja, Di Cataldo, Vanessa, Simontacchi, Gabriele, Marvaso, Giulia, Gandini, Sara, Corso, Federica, Ciccone, Lucia Pia, Zerella, Maria Alessia, Gentile, Piercarlo, Bianciardi, Federico, Allegretta, Sara, Detti, Beatrice, Desideri, Isacco, D’Angelillo, Rolando Maria, Masi, Laura, Ingrosso, Gianluca, Di Staso, Mario, Mazzeo, Ercole, Trippa, Fabio, Lohr, Frank, Bruni, Alessio, and Livi, Lorenzo

Published
2022
Full Text
View/download PDF

12. Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis

Author

Valeriani, Maurizio, Detti, Beatrice, Fodor, Andrei, Caini, Saverio, Borghesi, Simona, Trippa, Fabio, Triggiani, Luca, Bruni, Alessio, Russo, Donatella, Saldi, Simonetta, Di Staso, Mario, Francolini, Giulio, Lancia, Andrea, Marinelli, Luca, Di Muzio, Nadia, Aristei, Cynthia, Livi, Lorenzo, Magrini, Stefano Maria, and Ingrosso, Gianluca

Published
2022
Full Text
View/download PDF

13. The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC

Author

Perna, Marco, Scotti, Vieri, Ciammella, Patrizia, Borghetti, Paolo, D'angelo, Elisa, Levra, Niccolò Giaj, Fozza, Alessandra, Mariotti, Matteo, Salvestrini, Viola, Bertolini, Federica, Vagge, Stefano, Taraborrelli, Maria, Falcinelli, Lorenzo, Taddeo, Alessandra, Rossi, Roberto, Costantino, Gianluca, Frassinelli, Luca, Filippi, Andrea Riccardo, Greco, Carlo, Franceschini, Davide, Genovesi, Domenico, Lohr, Frank, Magrini, Stefano Maria, Alongi, Filippo, Livi, Lorenzo, and Bruni, Alessio

Published
2021
Full Text
View/download PDF

15. Dose-intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial

Author

Guckenberger, Matthias; https://orcid.org/0000-0002-7146-9071, Billiet, Charlotte; https://orcid.org/0000-0002-8483-850X, Schnell, Daniel, Franzese, Ciro; https://orcid.org/0000-0001-6893-6284, Spałek, Mateusz; https://orcid.org/0000-0002-3960-7673, Rogers, Susanne, Stelmes, Jean-Jacques; https://orcid.org/0000-0003-4887-6039, Aebersold, Daniel M; https://orcid.org/0000-0002-9493-3834, Hemmatazad, Hossein, Zimmermann, Frank, Zimmer, Jörg, Zilli, Thomas; https://orcid.org/0000-0002-4784-9883, Bruni, Alessio; https://orcid.org/0000-0003-1068-5958, Baumert, Brigitta G; https://orcid.org/0000-0001-8871-4654, Nägler, Franziska, Gut, Philipp, Förster, Robert, Madani, Indira, Guckenberger, Matthias; https://orcid.org/0000-0002-7146-9071, Billiet, Charlotte; https://orcid.org/0000-0002-8483-850X, Schnell, Daniel, Franzese, Ciro; https://orcid.org/0000-0001-6893-6284, Spałek, Mateusz; https://orcid.org/0000-0002-3960-7673, Rogers, Susanne, Stelmes, Jean-Jacques; https://orcid.org/0000-0003-4887-6039, Aebersold, Daniel M; https://orcid.org/0000-0002-9493-3834, Hemmatazad, Hossein, Zimmermann, Frank, Zimmer, Jörg, Zilli, Thomas; https://orcid.org/0000-0002-4784-9883, Bruni, Alessio; https://orcid.org/0000-0003-1068-5958, Baumert, Brigitta G; https://orcid.org/0000-0001-8871-4654, Nägler, Franziska, Gut, Philipp, Förster, Robert, and Madani, Indira

Abstract

BACKGROUND The purpose of this randomised study was to determine whether dose-intensified stereotactic body radiotherapy (SBRT) for painful vertebral metastases results in increased rates of pain improvement compared with conventional external beam radiotherapy (cEBRT) (control) 6 months after treatment. METHODS This randomized, controlled phase 3 trial was conducted between November 2016 and January 2023, when it was stopped early. Patients were eligible if they were aged 18 years or older; had one or two painful, stable, or potentially unstable vertebral metastases; and had a life expectancy of 1 year or longer according to the investigator's estimates. Patients received 48.5 grays (Gy) in 10 fractions (with epidural involvement) or 40 Gy in five fractions (without epidural involvement) in the SBRT group and 30 Gy in 10 fractions or 20 Gy in five fractions in the cEBRT group, respectively. The primary end point was an improvement in the pain score at the treated site by at least 2 points (on a visual analog scale from 0 to 10 points) at 6-month follow-up. Data were analyzed on an intention-to-treat and per-protocol basis. RESULTS Of 214 patients who were screened for eligibility, 63 were randomized 1:1 between SBRT (33 patients with 36 metastases) and cEBRT (30 patients with 31 metastases). The median age of all patients was 66 years, and 40 patients were men (63.5%). In the intention-to-treat analysis, the 6-month proportion of patients who had metastases with pain reduction by 2 or more points was significantly higher in the SBRT group versus the control group (69.4% vs. 41.9%, respectively; two-sided p = .02). Changes in opioid medication intake relative to baseline were nonsignificant between the groups. No differences were observed in vertebral compression fracture or adverse event rates between the groups. CONCLUSIONS Dose-intensified SBRT improved pain score more effectively than cEBRT at 6 months.

Published
2024

16. Dose‐intensified stereotactic body radiotherapy for painful vertebral metastases: A randomized phase 3 trial.

Author

Guckenberger, Matthias, Billiet, Charlotte, Schnell, Daniel, Franzese, Ciro, Spałek, Mateusz, Rogers, Susanne, Stelmes, Jean‐Jacques, Aebersold, Daniel M., Hemmatazad, Hossein, Zimmermann, Frank, Zimmer, Jörg, Zilli, Thomas, Bruni, Alessio, Baumert, Brigitta G., Nägler, Franziska, Gut, Philipp, Förster, Robert, and Madani, Indira

Subjects
CLINICAL trials, STEREOTACTIC radiotherapy, EXTERNAL beam radiotherapy, VERTEBRAL fractures, METASTASIS
Abstract

Background: The purpose of this randomised study was to determine whether dose‐intensified stereotactic body radiotherapy (SBRT) for painful vertebral metastases results in increased rates of pain improvement compared with conventional external beam radiotherapy (cEBRT) (control) 6 months after treatment. Methods: This randomized, controlled phase 3 trial was conducted between November 2016 and January 2023, when it was stopped early. Patients were eligible if they were aged 18 years or older; had one or two painful, stable, or potentially unstable vertebral metastases; and had a life expectancy of 1 year or longer according to the investigator's estimates. Patients received 48.5 grays (Gy) in 10 fractions (with epidural involvement) or 40 Gy in five fractions (without epidural involvement) in the SBRT group and 30 Gy in 10 fractions or 20 Gy in five fractions in the cEBRT group, respectively. The primary end point was an improvement in the pain score at the treated site by at least 2 points (on a visual analog scale from 0 to 10 points) at 6‐month follow‐up. Data were analyzed on an intention‐to‐treat and per‐protocol basis. Results: Of 214 patients who were screened for eligibility, 63 were randomized 1:1 between SBRT (33 patients with 36 metastases) and cEBRT (30 patients with 31 metastases). The median age of all patients was 66 years, and 40 patients were men (63.5%). In the intention‐to‐treat analysis, the 6‐month proportion of patients who had metastases with pain reduction by 2 or more points was significantly higher in the SBRT group versus the control group (69.4% vs. 41.9%, respectively; two‐sided p =.02). Changes in opioid medication intake relative to baseline were nonsignificant between the groups. No differences were observed in vertebral compression fracture or adverse event rates between the groups. Conclusions: Dose‐intensified SBRT improved pain score more effectively than cEBRT at 6 months. In this randomized clinical trial that included 63 patients with 67 painful vertebral metastases, the proportion of those who had metastases with pain improvement at 6‐month follow‐up was 69% in the stereotactic body radiotherapy group versus 42% in the conventional external beam radiotherapy group: a significant difference. Changes in opioid medication intake relative to baseline between the groups were not significant, and dose‐intensified stereotactic body radiotherapy was not associated with increased risks of adverse events. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

17. Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study

Author

Buti, Sebastiano, Bersanelli, Melissa, Viansone, Alessandro, Leonetti, Alessandro, Masini, Cristina, Ratta, Raffaele, Procopio, Giuseppe, Maines, Francesca, Iacovelli, Roberto, Ciccarese, Chiara, Vitale, Maria Giuseppa, De Giorgi, Ugo, Mucciarini, Claudia, Maruzzo, Marco, Prati, Giuseppe, Lattanzi, Elisabetta, Ciammella, Patrizia, Bruni, Alessio, Andreani, Stefano, and D'Abbiero, Nunziata

Published
2020
Full Text
View/download PDF

18. Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis

Author

Ciammella, Patrizia, primary, Cozzi, Salvatore, additional, Borghetti, Paolo, additional, Galaverni, Marco, additional, Nardone, Valerio, additional, Ruggieri, Maria Paola, additional, Sepulcri, Matteo, additional, Scotti, Vieri, additional, Bruni, Alessio, additional, Zanelli, Francesca, additional, Piro, Roberto, additional, Tagliavini, Elena, additional, Botti, Andrea, additional, Iori, Federico, additional, Alì, Emanuele, additional, Bennati, Chiara, additional, and Tiseo, Marcello, additional

Published
2024
Full Text
View/download PDF

19. Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques

Author

Carosi, Alessandra, Ingrosso, Gianluca, Turturici, Irene, Valeri, Silvio, Barbarino, Rosaria, Di Murro, Luana, Bottero, Marta, Lancia, Andrea, Ponti, Elisabetta, Bruni, Alessio, Bonzano, Elisabetta, Saldi, Simonetta, Andolina, Maria, Aristei, Cynthia, and Santoni, Riccardo

Published
2020
Full Text
View/download PDF

20. Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings

Author

Franceschini, Davide, Bruni, Alessio, Borghetti, Paolo, Giaj-Levra, Niccolò, Ramella, Sara, Buffoni, Lucio, Badellino, Serena, Andolina, Maria, Comin, Camilla, Vattemi, Emanuela, Bezzi, Michela, Trovò, Marco, Passaro, Antonio, Bearz, Alessandra, Chiari, Rita, Tindara, Franchina, Ferrari, Katia, Piperno, Gaia, Filippi, Andrea Riccardo, Genovesi, Domenico, and Scotti, Vieri

Published
2020
Full Text
View/download PDF

21. Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study

Author

Triggiani, Luca, Mazzola, Rosario, Magrini, Stefano Maria, Ingrosso, Gianluca, Borghetti, Paolo, Trippa, Fabio, Lancia, Andrea, Detti, Beatrice, Francolini, Giulio, Matrone, Fabio, Bortolus, Roberto, Fanetti, Giuseppe, Maranzano, Ernesto, Pasqualetti, Francesco, Paiar, Fabiola, Bonù, Marco Lorenzo, Magli, Alessandro, Bruni, Alessio, Mazzeo, Ercole, Franzese, Ciro, Scorsetti, Marta, Alongi, Filippo, Jereczek-Fossa, Barbara Alicja, Ost, Piet, and Buglione, Michela

Published
2019
Full Text
View/download PDF

23. Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis

Author

Scotti, Vieri, Bruni, Alessio, Francolini, Giulio, Perna, Marco, Vasilyeva, Polina, Loi, Mauro, Simontacchi, Gabriele, Viggiano, Domenico, Lanfranchi, Biancaluisa, Gonfiotti, Alessandro, Topulli, Juljana, Olmetto, Emanuela, Maragna, Virginia, Ferrari, Katia, Bonti, Viola, Comin, Camilla, Balduzzi, Sara, D’Amico, Roberto, Lohr, Frank, Voltolini, Luca, and Livi, Lorenzo

Published
2019
Full Text
View/download PDF

24. Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance

Author

Triggiani, Luca, Mazzola, Rosario, Tomasini, Davide, Bruni, Alessio, Alicino, Giulia, Matrone, Fabio, Bortolus, Roberto, Francolini, Giulio, Detti, Beatrice, Magli, Alessandro, Bonù, Marco Lorenzo, Ingrosso, Gianluca, Lancia, Andrea, Trippa, Fabio, Maranzano, Ernesto, Franzese, Ciro, Ghirardelli, Paolo, Vavassori, Vittorio, Scorsetti, Marta, Alongi, Filippo, and Magrini, Stefano Maria

Published
2021
Full Text
View/download PDF

25. PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality?

Author

Urso, Luca, primary, Filippi, Luca, additional, Castello, Angelo, additional, Marzola, Maria Cristina, additional, Bartolomei, Mirco, additional, Cittanti, Corrado, additional, Florimonte, Luigia, additional, Castellani, Massimo, additional, Zucali, Paolo, additional, Bruni, Alessio, additional, Sabbatini, Roberto, additional, Dominici, Massimo, additional, Panareo, Stefano, additional, and Evangelista, Laura, additional

Published
2023
Full Text
View/download PDF

28. Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial

Author

Pedretti, Sara, Masini, Laura, Turco, Enrico, Triggiani, Luca, Krengli, Marco, Meduri, Bruno, Pirtoli, Luigi, Borghetti, Paolo, Pegurri, Ludovica, Riva, Nada, Gatta, Roberto, Fusco, Vincenzo, Scoccianti, Silvia, Bruni, Alessio, Ricardi, Umberto, Santoni, Riccardo, Magrini, Stefano M., and Buglione, Michela

Published
2019
Full Text
View/download PDF

32. 424: SBRT after progression during abiraterone plus prednisone. A subgroup analysis from ARTO trial

Author

Francolini, Giulio, Di Cataldo, Vanessa, Garlatti, Pietro, Detti, Beatrice, Caini, Saverio, Bruni, Alessio, Ingrosso, Gianluca, D'angelillo, Rolando Maria, Alitto, Anna Rita, Augugliaro, Matteo, Triggiani, Luca, Parisi, Silvana, Facchini, Gaetano, Simontacchi, Gabriele, Desideri, Isacco, Meattini, Icro, Marvaso, Giulia, Jereczek-Fossa, Barbara Alicja, Alongi, Filippo, Arcidiacono, Fabio, Lancia, Andrea, Genovesi, Domenico, Franzese, Ciro, Scorsetti, Marta, and Livi, Lorenzo

Published
2024
Full Text
View/download PDF

33. Redetermination of PD-L1 expression after chemioradiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis.

Author

Ciammella, Patrizia, Cozzi, Salvatore, Borghetti, Paolo, Galaverni, Marco, Nardone, Valerio, Ruggieri, Maria Paola, Sepulcri, Matteo, Scotti, Vieri, Bruni, Alessio, Zanelli, Francesca, Piro, Roberto, Tagliavini, Elena, Botti, Andrea, Iori, Federico, Alì, Emanuele, Bennati, Chiara, and Tiseo, Marcello

Subjects
PROGRAMMED death-ligand 1, NON-small-cell lung carcinoma, PEMETREXED
Abstract

Background: Chemoradiation therapy (CRT) is the treatment of choice for locally advanced non-small cell lung cancer (LA-NSCLC). Several clinical trials that combine programmed cell death 1 (PD1) axis inhibitors with radiotherapy are in development for patients with LA-NSCLC. However, the effect of CRT on tumor cells programmed cell death ligand-1 (PD-L1) expression is unknown. Methods: In this multicentric retrospective study, we analyzed paired NSCLC specimens that had been obtained pre- and post-CRT. PD-L1 expression on tumor cells was studied by immunohistochemistry. The purpose of this study was to evaluate the feasibility, risk of complications, and clinical relevance of performing re-biopsy after CRT in patients with PD-L1 negative LA-NSCLC. Results: Overall, 31 patients from 6 centers with PD-L1 negative LA-NSCLC were analyzed. The percentage of tumor cells with PD-L1 expression significantly increased between pre- and post-CRT specimens in 14 patients (45%). Nine patients had unchanged PD-L1 expression after CRT, in five patients the rebiopsy material was insufficient for PD-L1 analysis and in two patients no tumor cells at rebiopsy were found. The post-rebiopsy complication rate was very low (6%). All patients with positive PD-L1 re-biopsy received Durvalumab maintenance after CRT, except one patient who had a long hospitalization for tuberculosis reactivation. Median PFS of patients with unchanged or increased PD-L1 expression was 10 and 16.9 months, respectively. Conclusion: CRT administration can induce PD-L1 expression in a considerable fraction of PD-L1 negative patients at baseline, allowing them receiving the maintenance Durvalumab in Europe. Hence, after a definitive CRT, PD-L1 redetermination should be considered in patients with LANSCLC PD-L1 negative, to have a better selection of maintenance Durvalumab candidates. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

34. Apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer: A randomized trial (PERSIAN).

Author

Francolini, Giulio, Porreca, Angelo, Facchini, Gaetano, Santini, Daniele, Bruni, Alessio, Simoni, Nicola, Trovò, Marco, Osti, Mattia Falchetto, Fornarini, Giuseppe, Sisani, Michele, Di Cataldo, Vanessa, Detti, Beatrice, Garlatti, Pietro, Bertini, Niccolò, Burchini, Luca, Frosini, Giulio, Bonaparte, Ilaria, Serni, Sergio, Minervini, Andrea, and Livi, Lorenzo

Published
2024
Full Text
View/download PDF

35. (ARTO trial-NCT03449719): Role of local treatment after progression in patients with castrate-resistant prostate cancer undergoing first-line abiraterone treatment.

Author

Francolini, Giulio, Di Cataldo, Vanessa, Detti, Beatrice, Garlatti, Pietro, Caini, Saverio, Bruni, Alessio, Ingrosso, Gianluca, D'Angelillo, Rolando Maria, Alitto, Anna Rita, Augugliaro, Matteo, Triggiani, Luca, Parisi, Silvana, Facchini, Gaetano, Banini, Marco, Simontacchi, Gabriele, Desideri, Isacco, Meattini, Icro, Valicenti, Richard K., and Livi, Lorenzo

Published
2024
Full Text
View/download PDF

36. ARTO trial: Overall survival analysis from a randomized phase II trial testing the benefit of adding stereotactic body radiotherapy to abiraterone acetate in patients with oligometastatic castrate-resistant prostate cancer.

Author

Francolini, Giulio, Di Cataldo, Vanessa, Garlatti, Pietro, Detti, Beatrice, Caini, Saverio, Bruni, Alessio, Ingrosso, Gianluca, D'Angelillo, Rolando Maria, Alitto, Anna Rita, Augugliaro, Matteo, Triggiani, Luca, Parisi, Silvana, Facchini, Gaetano, Banini, Marco, Simontacchi, Gabriele, Desideri, Isacco, Meattini, Icro, Valicenti, Richard K., and Livi, Lorenzo

Published
2024
Full Text
View/download PDF

37. Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO).

Author

Francolini, Giulio, Gaetano Allegra, Andrea, Detti, Beatrice, Di Cataldo, Vanessa, Caini, Saverio, Bruni, Alessio, Ingrosso, Gianluca, D'Angelillo, Rolando Maria, Alitto, Anna Rita, Augugliaro, Matteo, Triggiani, Luca, Parisi, Silvana, Facchini, Gaetano, Banini, Marco, Simontacchi, Gabriele, Desideri, Isacco, Meattini, Icro, Valicenti, Richard K., Livi, Lorenzo, and Marvaso, Giulia

Published
2023
Full Text
View/download PDF

39. Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature

Author

Bruni, Alessio, primary, Bertolini, Federica, additional, D’Angelo, Elisa, additional, Guaitoli, Giorgia, additional, Imbrescia, Jessica, additional, Cappelli, Anna, additional, Guidi, Gabriele, additional, Stefani, Alessandro, additional, Dominici, Massimo, additional, and Lohr, Frank, additional

Published
2023
Full Text
View/download PDF

40. Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study

Author

Cozzi, Salvatore, primary, Bruni, Alessio, additional, Ruggieri, Maria Paola, additional, Borghetti, Paolo, additional, Scotti, Vieri, additional, Franceschini, Davide, additional, Fiore, Michele, additional, Taraborrelli, Maria, additional, Salvi, Fabrizio, additional, Galaverni, Marco, additional, Savoldi, Luisa, additional, Braglia, Luca, additional, Botti, Andrea, additional, Finocchi Ghersi, Sebastiano, additional, Niccolò, Giaj-Levra, additional, Lohr, Frank, additional, Iotti, Cinzia, additional, and Ciammella, Patrizia, additional

Published
2023
Full Text
View/download PDF

41. Pros-IT CNR: an Italian prostate cancer monitoring project

Author

Noale, Marianna, Maggi, Stefania, Artibani, Walter, Bassi, Pier Francesco, Bertoni, Filippo, Bracarda, Sergio, Conti, Giario Natale, Corvò, Renzo, Gacci, Mauro, Graziotti, Pierpaolo, Magrini, Stefano Maria, Maurizi Enrici, Riccardo, Mirone, Vincenzo, Montironi, Rodolfo, Muto, Giovanni, Pecoraro, Stefano, Porreca, Angelo, Ricardi, Umberto, Tubaro, Andrea, Zagonel, Vittorina, Zattoni, Filiberto, Crepaldi, Gaetano, Crepaldi, Gaetano, Maggi, Stefania, Noale, Marianna, Porreca, Angelo, Artibani, Walter, Bassi, Pier Francesco, Bracarda, Sergio, Conti, Giario Natale, Corvò, Renzo, Graziotti, Pierpaolo, Maurizi Enrici, Riccardo, Mirone, Vincenzo, Montironi, Rodolfo, Bertoni, Filippo, Gacci, Mauro, Magrini, Stefano Maria, Muto, Giovanni, Pecoraro, Stefano, Ricardi, Umberto, Tubaro, Andrea, Zagonel, Vittorina, Zattoni, Filiberto, Alitto, Anna Rita, Ambrosi, Enrica, Antonelli, Alessandro, Aristei, Cynthia, Barbieri, Michele, Bardari, Franco, Bardoscia, Lilia, Barra, Salvina, Bartoncini, Sara, Basso, Umberto, Becherini, Carlotta, Bellavita, Rita, Bergamaschi, Franco, Berlingheri, Stefania, Berruti, Alfredo, Borghesi, Marco, Bortolus, Roberto, Borzillo, Valentina, Bosetti, Davide, Bove, Giuseppe, Bove, Pierluigi, Brausi, Maurizio, Bruni, Alessio, Bruno, Giorgio, Brunocilla, Eugenio, Buffoli, Alberto, Buglione, Michela, Buttigliero, Consuelo, Cacciamani, Giovanni, Caldiroli, Michela, Cardo, Giuseppe, Carmignani, Giorgio, Carrieri, Giuseppe, Castelli, Emanuele, Castrezzati, Elisabetta, Catalano, Gianpiero, Cattarino, Susanna, Catucci, Francesco, Cavallini Francolini, Dario, Ceccarini, Ofelia, Celia, Antonio, Chiancone, Francesco, Chini, Tommaso, Cianci, Claudia, Cisternino, Antonio, Collura, Devis, Corbella, Franco, Corinti, Matteo, Corsi, Paolo, Cortese, Fiorenza, Corti, Luigi, de Nunzio, Cosimo, Cristiano, Olga, D’Angelillo, Rolando, Da Pozzo, Luigi, D’agostino, Daniele, D’Andrea, David, Dandrea, Matteo, De Angelis, Michele, De Cobelli, Ottavio, De Concilio, Bernardino, De Lisa, Antonello, De Luca, Stefano, De Stefani, Agostina, Deantoni, Chiara Lucrezia, Degli Esposti, Claudio, Destito, Anna, Detti, Beatrice, Di Muzio, Nadia, Di Stasio, Andrea, Di Stefano, Calogero, Di Trapani, Danilo, Difino, Giuseppe, Falivene, Sara, Farullo, Giuseppe, Fedelini, Paolo, Ferrari, Ilaria, Ferrau, Francesco, Ferro, Matteo, Fodor, Andrei, Fontana, Francesco, Francesca, Francesco, Giulio, Francolini, Frata, Paolo, Frezza, Giovanni, Gabriele, Pietro, Galeandro, Maria, Garibaldi, Elisabetta, Gennari, Pietro, Gentilucci, Alessandro, Giacobbe, Alessandro, Giussani, Laura, Giusti, Giuseppe, Gontero, Paolo, Guarneri, Alessia, Guida, Cesare, Gurioli, Alberto, Huqi, Dorijan, Imbimbo, Ciro, Ingrosso, Gianluca, Iotti, Cinzia, Italia, Corrado, La Mattina, Pierdaniele, Lamanna, Enza, Lastrucci, Luciana, Lazzari, Grazia, Liberale, Fabiola, Liguori, Giovanni, Lisi, Roberto, Lohr, Frank, Lombardo, Riccardo, Lovisolo, Jon, Ludovico, Giuseppe Mario, Macchione, Nicola, Maggio, Francesca, Malizia, Michele, Manasse, Gianluca, Mandoliti, Giovanni, Mantini, Giovanna, Marafioti, Luigi, Marciello, Luisa, Marconi, Alberto Mario, Martillotta, Antonietta, Marzano, Salvino, Masciullo, Stefano, Maso, Gloria, Massenzo, Adele, Mazzeo, Ercole, Mearini, Luigi, Medoro, Serena, Molè, Rosa, Monesi, Giorgio, Montanari, Emanuele, Montefiore, Franco, Montesi, Giampaolo, Morgia, Giuseppe, Moro, Gregorio, Muscas, Giorgio, Musio, Daniela, Muto, Paolo, Muzzonigro, Giovanni, Napodano, Giorgio, Negro, Carlo Luigi Augusto, Nidini, Mattia, Ntreta, Maria, Orsatti, Marco, Palazzolo, Carmela, Palumbo, Isabella, Parisi, Alessandro, Parma, Paolo, Pavan, Nicola, Pericolini, Martina, Pinto, Francesco, Pistone, Antonio, Pizzuti, Valerio, Platania, Angelo, Polli, Caterina, Pomara, Giorgio, Ponti, Elisabetta, Porcaro, Antonio Benito, Porpiglia, Francesco, Pugliese, Dario, Pycha, Armin, Raguso, Giuseppe, Rampini, Andrea, Randone, Donato Franco, Roscigno, Marco, Ruggieri, Maria Paola, Ruoppo, Giuseppe, Sanseverino, Roberto, Santacaterina, Anna, Santarsieri, Michele, Santoni, Riccardo, Scagliarini, Sarah, Scagliotti, Giorgio Vittorio, Scanzi, Mauro, Scarcia, Marcello, Schiavina, Riccardo, Sciarra, Alessandro, Sciorio, Carmine, Scolaro, Tindaro, Scuzzarella, Salvatore, Selvaggio, Oscar, Serao, Armando, Serni, Sergio, Signor, Marco Andrea, Silvani, Mauro, Silvano, Giovanni, Silvestris, Franco, Simeone, Claudio, Simone, Valeria, Spagnoletti, Girolamo, Spinelli, Matteo Giulio, Squillace, Luigi, Tombolini, Vincenzo, Toninelli, Mariastella, Triggiani, Luca, Trinchieri, Alberto, Trodella, Luca Eolo, Trodella, Lucio, Trombetta, Carlo, Tronnolone, Lidia, Tucci, Marcello, Urzì, Daniele, Valdagni, Riccardo, Valeriani, Maurizio, Vanoli, Maurizio, Vitali, Elisabetta, Zaramella, Stefano, Zeccolini, Guglielmo, Zini, Giampaolo, and the Pros-IT CNR study group

Published
2017
Full Text
View/download PDF

42. Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T

Author

Guaitoli, Giorgia, primary, Neri, Giovanni, additional, Cabitza, Eleonora, additional, Natalizio, Salvatore, additional, Mastrodomenico, Luciana, additional, Talerico, Sabrina, additional, Trudu, Lucia, additional, Lauro, Chiara, additional, Chiavelli, Chiara, additional, Baschieri, Maria Cristina, additional, Bruni, Alessio, additional, Dominici, Massimo, additional, and Bertolini, Federica, additional

Published
2022
Full Text
View/download PDF

43. A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC

Author

Imbrescia, Jessica, primary, Volpi, Giulia, additional, Lucchini, Silvia, additional, Toraci, Cristian, additional, Facheris, Giorgio, additional, La Mattina, Salvatore, additional, Singh, Navdeep, additional, Vaccher, Filippo, additional, Guerini, Andrea, additional, Buglione di Monale e Bastia, Michela, additional, Bruni, Alessio, additional, and Borghetti, Paolo, additional

Published
2022
Full Text
View/download PDF

44. Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment Radiomodulation

Author

Iori, Federico, primary, Bruni, Alessio, additional, Cozzi, Salvatore, additional, Ciammella, Patrizia, additional, Di Pressa, Francesca, additional, Boldrini, Luca, additional, Greco, Carlo, additional, Nardone, Valerio, additional, Salvestrini, Viola, additional, Desideri, Isacco, additional, De Felice, Francesca, additional, and Iotti, Cinzia, additional

Published
2022
Full Text
View/download PDF

45. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study

Author

Masini, Cristina, primary, Iotti, Cinzia, additional, De Giorgi, Ugo, additional, Bellia, Roberto Salvatore, additional, Buti, Sebastiano, additional, Salaroli, Francesco, additional, Zampiva, Ilaria, additional, Mazzarotto, Renzo, additional, Mucciarini, Claudia, additional, Vitale, Maria Giuseppa, additional, Bruni, Alessio, additional, Lohr, Frank, additional, Procopio, Giuseppe, additional, Caffo, Orazio, additional, Nole, Franco, additional, Morelli, Franco, additional, Baier, Susanne, additional, Buttigliero, Consuelo, additional, Ciammella, Patrizia, additional, Timon, Giorgia, additional, Fantinel, Emanuela, additional, Carlinfante, Gabriele, additional, Berselli, Annalisa, additional, and Pinto, Carmine, additional

Published
2022
Full Text
View/download PDF

46. Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy

Author

Guerini, Andrea, Noale, Marianna, Mortellaro, Gianluca, Lisi, Roberto, Bruni, Alessio, Santini, Roberto, Muto, Paolo, Ferrera, Giuseppe, Cossali, Gianluca, Morelli, Vittorio, Magrini, Stefano Maria, Spiazzi, Luigi, and Buglione, Michela

Subjects
IMRT (intensity modulated radiation therapy), pelvic nodal irradiation, IGRT (Image Guided Radiation Therapy), ADT, VMAT (volumetric modulated arc therapy), prostate cancer, radiotherapy
Published
2022

48. ARTO trial-(NCT03449719): Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration-resistant prostate cancer undergoing I line treatment with abiraterone acetate.

Author

Francolini, Giulio, primary, Detti, Beatrice, additional, Di Cataldo, Vanessa, additional, Caini, Saverio, additional, Alitto, Anna Rita, additional, Parisi, Silvana, additional, Demofonti, Chiara, additional, Bruni, Alessio, additional, Ingrosso, Gianluca, additional, Timon, Giorgia, additional, Allegra, Andrea, additional, Aquilano, Michele, additional, Ciccone, Lucia Pia, additional, Salvestrini, Viola, additional, Frosini, Giulio, additional, Cerbai, Cecilia, additional, Desideri, Isacco, additional, Meattini, Icro, additional, Mangoni, Monica, additional, and Livi, Lorenzo, additional

Published
2022
Full Text
View/download PDF

49. Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial

Author

Bonù, Marco Lorenzo, primary, Magli, Alessandro, additional, Tomasini, Davide, additional, Frassine, Francesco, additional, Albano, Domenico, additional, Arcangeli, Stefano, additional, Bruni, Alessio, additional, Ciccarelli, Stefano, additional, De Angeli, Martina, additional, Francolini, Giulio, additional, Franzese, Ciro, additional, Ghirardelli, Paolo, additional, Grazioli, Luigi, additional, Guerini, Andrea, additional, Lancia, Andrea, additional, Marvaso, Giulia, additional, Sepulcri, Matteo, additional, Trodella, Luca Eolo, additional, Morelli, Vittorio, additional, Georgopulos, Andrea, additional, Domina, Anastasiya Oleksandrivna, additional, Granello, Lorenzo, additional, Mataj, Eneida, additional, Barbera, Fernando, additional, and Triggiani, Luca, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results